Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
12/19/1996 | WO1996040270A1 In vitro packaging of adeno-associated virus dna |
12/19/1996 | WO1996040269A1 INCREASING rAAV TITER |
12/19/1996 | WO1996040268A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
12/19/1996 | WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens |
12/19/1996 | WO1996040266A1 Method of treatment for asthma |
12/19/1996 | WO1996040265A1 Stabilization of polynucleotide complexes |
12/19/1996 | WO1996040264A1 Separation of active complexes |
12/19/1996 | WO1996040240A1 Helper virus-free aav production |
12/19/1996 | WO1996040238A1 Vectors for the diagnosis and treatment of solid tumors including melanoma |
12/19/1996 | WO1996040212A1 Retrovirus vectors for expression of cii-ta and activation of hla class ii gene expression and uses thereof |
12/19/1996 | WO1996040209A1 Method for identifying or isolating a molecule and molecules identified thereby |
12/19/1996 | WO1996040199A1 Methods of inhibiting phagocytosis |
12/19/1996 | WO1996040195A1 Gene therapy for myocardial ischemia |
12/19/1996 | WO1996040178A1 Use of co-localized islets and sertoli cells in xenograft cellular transplants |
12/19/1996 | WO1996040162A1 Method of treatment for lung diseases using antisense oligonucleotides |
12/19/1996 | WO1996040159A1 Capped synthetic rna, analogs, and aptamers |
12/19/1996 | WO1996040081A2 Oral delivery of gene constructs |
12/19/1996 | WO1996040068A1 Methods and system for processing dispersible fine powders |
12/19/1996 | WO1996040067A1 Cationic lipid acid salt of 3 beta [n-(n',n'-dimethylaminoethane)-carbamoyl] cholesterol |
12/19/1996 | WO1996040040A2 Thrombin receptor homolog |
12/19/1996 | WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof |
12/19/1996 | WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication |
12/19/1996 | WO1996039830A1 Pericardial therapeutic and diagnostic agent delivery |
12/19/1996 | DE19521412A1 Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung New cationic and polycationic amphiphiles containing these reagents and their use |
12/19/1996 | DE19521314A1 Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid Adhärenzgen from Helicobacter pylori and it polypeptide encoded |
12/19/1996 | CA2226463A1 Recombinational cloning using engineered recombination sites |
12/19/1996 | CA2224226A1 Immunoprotective barrier for transplantation of cells |
12/19/1996 | CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
12/19/1996 | CA2224114A1 Synthetic mammalian chromosome and methods for construction |
12/19/1996 | CA2224099A1 Monocyte chemotactic protein-4 |
12/19/1996 | CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens |
12/19/1996 | CA2224064A1 Methods and system for processing dispersible fine powders |
12/19/1996 | CA2223969A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
12/19/1996 | CA2223934A1 Separation of active complexes |
12/19/1996 | CA2223928A1 Cationic lipid:dna complexes for gene targeting |
12/19/1996 | CA2223923A1 Cationic lipid:dna complexes for gene targeting |
12/19/1996 | CA2223921A1 Stabilization of polynucleotide complexes |
12/19/1996 | CA2223891A1 Treatment of insulin resistance |
12/19/1996 | CA2223717A1 Modified steroid hormones for gene therapy and methods for their use |
12/19/1996 | CA2223610A1 Nucleic acid respiratory syncytial virus vaccines |
12/19/1996 | CA2223584A1 Crosslinking oligonucleotides |
12/19/1996 | CA2223549A1 Capped synthetic rna, analogs, and aptamers |
12/19/1996 | CA2223395A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
12/19/1996 | CA2223246A1 Cell line producing analgesic compounds for treating pain |
12/19/1996 | CA2223179A1 Phosphonic acid-based cationic lipids |
12/19/1996 | CA2223077A1 Thrombin receptor homolog |
12/19/1996 | CA2222793A1 Optimized minizymes and miniribozymes and uses thereof |
12/19/1996 | CA2222574A1 Oral delivery of adeno-associated viral vectors |
12/19/1996 | CA2222550A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
12/19/1996 | CA2222534A1 In vitro packaging of adeno-associated virus dna |
12/19/1996 | CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna |
12/19/1996 | CA2222162A1 Pericardial therapeutic and diagnostic agent delivery |
12/19/1996 | CA2221821A1 Endothelial-monocyte activating polypeptide iii |
12/19/1996 | CA2221710A1 Gene therapy for myocardial ischemia |
12/19/1996 | CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
12/19/1996 | CA2221602A1 Essential oligonucleotides of vertebrate telomerase |
12/19/1996 | CA2221323A1 Oral delivery of gene constructs |
12/18/1996 | EP0748870A2 Oncostatin M induced hematopoiesis |
12/18/1996 | EP0748631A2 Viral vaccines |
12/18/1996 | EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
12/18/1996 | EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
12/18/1996 | EP0748376A1 Rna editing enzyme and methods of use thereof |
12/18/1996 | EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained |
12/18/1996 | CN1138295A A novel tumor suppressor gene |
12/17/1996 | US5585362 Adenovirus vectors for gene therapy |
12/17/1996 | US5585263 Nucleotide sequence effecting the rev-dependent expression of structural proteins, gag, pol and env, in the absence of rev expression; hiv vaccine; |
12/17/1996 | US5585096 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
12/17/1996 | US5584807 Gas driven gene delivery instrument |
12/16/1996 | WO1996039508A1 Fibroblast growth factor 13 |
12/16/1996 | CA2220988A1 Fibroblast growth factor 13 |
12/12/1996 | WO1996039541A1 Colon specific gene and protein |
12/12/1996 | WO1996039540A1 Novel gene-up regulated in regenerating liver |
12/12/1996 | WO1996039531A1 Delivery of nucleotides into organisms by electroporation |
12/12/1996 | WO1996039530A2 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
12/12/1996 | WO1996039524A1 Methods for enhancement of protective immune responses |
12/12/1996 | WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1 |
12/12/1996 | WO1996039521A1 Human chemokine beta-13 |
12/12/1996 | WO1996039517A1 The erf genetic locus and its products |
12/12/1996 | WO1996039516A2 Targets for breast cancer diagnosis and treatment |
12/12/1996 | WO1996039515A1 Human vascular endothelial growth factor 2 |
12/12/1996 | WO1996039514A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
12/12/1996 | WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
12/12/1996 | WO1996039509A1 Fibroblast growth factor 15 |
12/12/1996 | WO1996039507A1 Fibroblast growth factor 11 |
12/12/1996 | WO1996039506A1 Fibroblast growth factor-14 |
12/12/1996 | WO1996039499A1 TNF-α RIBOZYMES, TNF-α RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES |
12/12/1996 | WO1996039497A1 Transforming growth factor alpha hi |
12/12/1996 | WO1996039496A1 Use of neuro-derived fetal cell lines for transplantation therapy |
12/12/1996 | WO1996039495A1 Aav directed targeted integration |
12/12/1996 | WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses |
12/12/1996 | WO1996039490A1 Organ function replacement compositions and methods of making and using the same |
12/12/1996 | WO1996039485A1 Human hepatoma-derived growth factor-2 |
12/12/1996 | WO1996039442A1 G-protein receptor htnad29 |
12/12/1996 | WO1996039439A1 Human g-protein receptor hcegh45 |
12/12/1996 | WO1996039438A1 G-protein receptor hibeb69 |
12/12/1996 | WO1996039437A1 Human g-protein chemokine receptor hdgnr10 |
12/12/1996 | WO1996039435A1 Human g-protein receptor hpraj70 |
12/12/1996 | WO1996039434A1 Human g-protein receptor hgber32 |
12/12/1996 | WO1996039431A1 Bone morphogenic protein-10 |
12/12/1996 | WO1996039426A1 Hypoxia inducible factor-1 and method of use |